Merck and Siemens Forge Alliance to Accelerate the Future of Smart Manufacturing

Cedrik Neike, CEO Digital Industries and Member of the Managing Board of Siemens AG, signing MoU and Kai Beckmann, CEO Electronics business and Member of the Executive Board of Merck.

(IN BRIEF) Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, modular production systems. Siemens will become Merck’s preferred global supplier, providing advanced hardware and software solutions via the Siemens Xcelerator platform. The collaboration aims to increase production speed, flexibility, and sustainability across Merck’s healthcare, life sciences, and electronics sectors. This partnership builds on over 145 years of cooperation and sets new standards for future manufacturing, with a recent success in GMP-compliant modular production lines for Merck’s pharmaceutical and chemical products.

(PRESS RELEASE) DARMSTADT, 16-Sep-2024 — /EuropaWire/ —  Siemens AG (ETR: SIE), a German multinational conglomerate and Europe’s largest industrial manufacturing company, and Merck, a global leader in science and technology have entered into a strategic partnership to accelerate digital transformation through advanced smart manufacturing solutions. This collaboration was formalized with the signing of a Memorandum of Understanding (MoU), making Siemens a preferred global supplier of Smartfacturing technology for Merck’s healthcare, life sciences, and electronics sectors. The partnership aims to revolutionize manufacturing by adopting modular production systems, powered by Siemens’ Xcelerator platform, which will enable faster, more flexible, and sustainable production processes.

Cedrik Neike, CEO of Siemens Digital Industries, emphasized the significance of the partnership, highlighting how it will transition manufacturing from traditional mass production to a more modular and efficient model. Merck’s CEO of Electronics, Kai Beckmann, expressed confidence that this partnership will allow Merck to bring products to market faster, with a greater focus on cost efficiency and sustainability.

One recent success from the collaboration is the implementation of a modular manufacturing line based on the MTP (Module Type Package) automation standard, which ensures high-quality, GMP-compliant production for Merck’s pharmaceutical and chemical products. This innovation is expected to be scalable across multiple industries, marking a key advancement in the digital transformation of global manufacturing.

The partnership between Merck and Siemens, built on over 145 years of cooperation, aims to set new global standards for smart, sustainable manufacturing, driving growth and innovation for both companies.

Siemens AG (Berlin and Munich) is a leading technology company focused on industry, infrastructure, mobility, and healthcare. The company’s purpose is to create technology to transform the everyday, for everyone. By combining the real and the digital worlds, Siemens empowers customers to accelerate their digital and sustainability transformations, making factories more efficient, cities more livable, and transportation more sustainable. Siemens also owns a majority stake in the publicly listed company, Siemens Healthineers, a leading global medical technology provider shaping the future of healthcare. In fiscal 2023, which ended on September 30, 2023, the Siemens Group generated revenue of €74.9 billion and net income of €8.5 billion. As of September 30, 2023, the company employed around 305,000 people worldwide on the basis of continuing operations. Further information is available on the Internet at www.siemens.com.

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

Media Contacts:

Jil Huber
Siemens AG
+49 162 3474144
jil-patricia.huber@siemens.com

Christoph Krösmann
Siemens AG
+49 162 7436402
christoph.kroesmann@siemens.com

Adrian Woitzik
Merck
+49 151 1454-7499
adrian.woitzik@merckgroup.com

SOURCE: Siemens AG